This report describes the clinical laboratory findings in golden hamsters experimentally infected with yellow fever (YF) virus. An accompanying paper describes the pathologic findings. Following intraperitoneal inoculation of a virulent strain of YF virus, hamsters developed a high-titered viremia (up to 109/mL) lasting 5-6 days and abnormal liver function tests. YF hemagglutination-inhibiting antibodies appeared 4 or 5 days after infection, often while viremia was still present. The mortality rate in YF-infected hamsters was variable, depending on the virus strain and the age of the animals. Clinical and pathologic changes in the infected hamsters were very similar to those described in experimentally infected macaques and in fatal human cases of YF, which indicates that the golden hamster may be an excellent alternative animal model, in place of nonhuman primates, for research on the pathogenesis and treatment of YF and other viscerotropic flavivirus diseases.
on the epidemiology and pathology of YF was done using rhesus monkeys [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] ; however, the current expense and regulatory obstacles involved in the use of nonhuman primates now make such experimental work almost prohibitive. Consequently, other animal models of the disease are needed so that the pathogenesis of YF can be studied by using modern techniques [1, 2] .
We have developed a new hamster model of YF that manifests many of the clinical and pathologic findings of severe YF in humans and macaques. This paper describes the development of the model and the clinical, virologic, and immunologic findings in experimentally infected animals. An accompanying paper [17] describes the pathologic and immunohistochemical findings in organs of infected hamsters.
Methods
Animals. The hamsters used in our studies were 4-10-weekold female Syrian golden hamsters (Mesocricetus auratus) obtained from Harlan Sprague Dawley.
Viruses. Two YF virus strains were used: strain BeH 413820, which was isolated from a human case in Rondonia State, Brazil, in 1983, and the Jimenez strain, which was isolated from a fatal human case in Panama in 1974. YF virus strain BeH 413820 had 1 previous passage each in newborn mice and in mosquito cell (C6/36) culture. Two different passage levels of the Jimenez strain were used and are designated "p.0" and "p. 10 ." The p.0 strain had 1 previous monkey (Aotus trivirgatus) passage; the p.10 strain had an additional 10 serial passages in adult hamsters, as described below.
A single hamster was inoculated intraperitoneally (ip) with the p.0 strain of the Jimenez YF virus. On day 3 after inoculation, the hamster was killed; a portion of the liver was removed and homogenized in PBS (pH 7.4), and 0.2 mL of the crude liver suspension was inoculated ip into another hamster. This procedure was repeated 9 times. Liver removed from a hamster after the tenth serial passage was used to prepare a large virus stock (p.10), which was used in subsequent experimental infections. The titer of the p.10 Jimenez YF virus stock was 107.0 TCID 50 U/mL, as titrated in C6/36 cells by using immunofluorescence assay [18] .
Immune reagents. Mouse immune ascitic fluid (MIAF) to YF virus was prepared in adult IRC mice. The immunogen used for preparation of MIAF was a crude brain homogenate (10% wt/vol in PBS) of newborn mice inoculated intracerebrally with the Asibi strain of YF virus. The adult immunization schedule consisted of 4 ip injections of the immunogen mixed with Freund's adjuvant, which was given at weekly intervals. Sarcoma 180 cells were given after the final injection, to induce ascites formation.
Antibody determinations. Antibodies to YF virus in the infected animals were measured by hemagglutination-inhibition (HI) test, according to established protocols [19] . Hemagglutinin antigens were prepared from YF virus-infected newborn mouse brain, using the sucrose-acetone extraction method [19] . Hamster serum samples were tested by HI at serial 2-fold dilutions from 1:20 to 1:2560 (pH 6.4), using 4 U of antigen and a 1:200 dilution of goose erythrocytes.
Virus titrations. Titrations of daily blood samples from the infected hamsters were done in 24-well tissue culture plates seeded with C6/36 cells. Serial 10-fold dilutions from 10 Ϫ1 to 10 Ϫ7 were made of each blood specimen, using PBS with 10% heat-inactivated (60ЊC for 20 min) fetal bovine serum as the diluent. Four wells of the tissue culture plate were inoculated with 0.1 mL of each dilution. After absorption at 28ЊC for 2 h, 1.5 mL of maintenance medium [18] was added to each well, and the plates were incubated at 28ЊC in a 5% CO 2 atmosphere for 6 days. On the sixth day after inoculation, 20 mL of a cell suspension from each well was added to a single spot on 12-spot glass microscope slides (Cell-Line Associates). After drying at room temperature, the slides were immersed in cold acetone for 10 min; the cells were examined subsequently for the presence of YF viral antigen by indirect fluorescent antibody test, using the YF-specific MIAF and a commercially prepared fluorescein-conjugated, goat antimouse immunoglobulin (Sigma), as described elsewhere [18] . YF virus titers in the blood were calculated as the TCID 50 /mL, using the method of Reed and Muench [20] .
Hematologic studies. Blood samples for hematologic and liverfunction studies were obtained by cardiac puncture. Blood for hematocrit and total white blood cell (WBC) determinations were collected in Vacutainer tubes with 7.5% EDTA (Becton Dickinson). Hematocrit values were determined by using a centrifugal hematology system (QBC Autoread Plus; Becton Dickinson). WBCs were counted manually by use of a hemocytometer (Newbauer; American Optical) and the Unopette (Becton Dickinson) white blood cell test system.
Liver-function studies. Determinations of total bilirubin and levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were done on fresh serum from clotted blood, using commercial kits (Total Bilirubin, Infinity ALT, and Infinity AST; Sigma Diagnostics), according to the manufacturer's instructions.
Infection of hamsters. All animals were inoculated ip with 0.1 mL of the respective YF virus stock. After infection, blood samples were obtained at daily intervals by cardiac puncture or from the retroorbital sinus. Hamsters were anesthetized with halothane before samples were obtained. In some experiments, blood samples were obtained at daily intervals from the same animals to follow the level and duration of YF viremia and the animals' immune responses. In these studies, animals were bled from the retroortibal sinus, and ∼0.2 mL of blood was obtained every 24 h. In other experiments [17] , when larger volumes of blood and tissue samples were needed, several animals were killed each day. The animals were exsanguinated under anesthesia by cardiac puncture and immediately were necropsied, and samples of liver, spleen, lung, heart, pancreas, kidney, and adrenal were removed and were placed in 10% buffered formalin for subsequent histopathologic examination. Results of the latter studies are described in the accompanying paper [17] .
Results
Initial development of hamster model. Our initial impetus for infecting hamsters with YF virus was to use them as viremic hosts to feed mosquitoes in studies of vector competence. This interest was based on our earlier unpublished observations that adult hamsters inoculated with YF virus subsequently developed a transient viremia. In preliminary studies, hamsters were inoculated ip with untitrated stocks of 4 different strains of YF virus (BeH 413820, Jimenez, Asibi, and A709-4A2), and the level and duration of the subsequent viremia were determined. After inoculation, the animals developed a transient but significant viremia that lasted 3-5 days (data not shown). Of the 4 YF strains tested initially, the Jimenez (p.0) strain gave the highest levels of viremia; it was also the only strain that produced mortality in the hamsters.
On the basis of these preliminary results, it was decided to serially pass liver suspensions 10 times from the Jimenez virus-infected hamsters, to produce a more virulent phenotype. The resulting virus strain, designated "Jimenez p.10," produced a higher and longer viremia in the hamsters than did the p.0 strain, although it did not appear to be more lethal (table 1) . Hamsters inoculated with the Jimenez p.10 strain also appeared to be clinically ill, manifesting lethargy, loss of appetite, and ruffled fur on days 5 and 6 after infection; however, many of the animals subsequently recovered and survived.
Viremia and immune response. Table 1 shows the levels of viremia and HI antibody responses of individual hamsters tested 1-7 days after being infected with the Jimenez p.0 and p.10 virus strains. Blood samples were obtained daily for 7 consecutive days (or until death) from animals numbered H-3021-H-3100. In contrast, the hamsters numbered H-1-H-8 were killed at the time when blood samples were obtained; thus, the results given for each day after infection in the latter group represent the values obtained on 8 different animals per time period. Nonetheless, the combined results indicate that most of the hamsters infected with 10 6 TCID 50 of the Jimenez p.10 YF virus strain developed detectable viremia within 24 h and that infectious virus was present in the blood for 5 or 6 days. Maximum blood virus titers generally occurred on day 3 after infection. HI antibodies appeared 4-5 days after infection. On Table 1 . Viremia and hemagglutination-inhibition (HI) antibody levels in hamsters inoculated with 10 6 TCID 50 of 2 passage levels (p.0 and p.10) of the Jimenez yellow fever virus.
Virus strain, animal no. day 5, many of the animals still had detectable viremia in the presence of increasing HI antibody levels. These results are summarized in figure 1. By day 6 after infection, most of the hamsters had high HI antibody titers, and infectious virus was usually not detectable in their blood. All animals still alive on day 7 survived the infection.
Day after infection
Hamsters infected with the p.0 strain of the Jimenez YF virus had a similar antibody response, but the level of viremia was lower, and the duration was shorter (table 1) .
Hematologic response. Table 2 shows the level of viremia, HI antibody titer, total WBC count, hematocrit level, total bilirubin, and AST and ALT levels for 34 hamsters killed 1-9 days after being infected with the p.10 Jimenez strain. On the basis of these values, many of the YF virus-infected hamsters had an elevated WBC count on days 6-8 after infection. The elevation of peripheral leukocytes coincided with the increased number of inflammatory cells observed in histological sections of liver of the hamsters on the same days [17] .
Hematocrit values among the infected hamsters showed little change over the 9-day period (table 2). The slight elevation observed on days 5 and 6 was probably due to dehydration and hemoconcentration, since the hamsters were lethargic and were not eating during this period.
Liver-function studies. The reported ranges for total bilirubin and AST and ALT levels in normal adult female golden (Syrian) hamsters are as follows: bilirubin level, 0.1-0.9 mg/dL; AST level, 33-189 U/L; and ALT level, 28-119 U/L [21, 22] . On the basis of these reference values, the AST levels in the infected hamsters were elevated on days 4-6. ALT levels, which are a more specific measure of hepatic necrosis, also were mark- edly elevated on days 4-6. The ALT levels still were elevated on days 7 and 8 but appeared to be declining. A significant elevation in total bilirubin in the serum of the infected hamsters occurred on day 5 and persisted in most animals until day 8 (table 2) . Although jaundice could not be observed in the infected hamsters, their serum samples were visibly icteric during this period. Figure 2 shows the relationship of daily mean bilirubin and ALT values in serum samples of hamsters after infection with the Jimenez p.10 virus. The temporal pattern suggests that the elevation in total serum bilirubin followed the massive necrosis of hepatocytes evidenced by the marked elevation of ALT on day 4 and as confirmed by histopathology [17] .
Mortality rate. The mortality rate among hamsters infected with the p.10 Jimenez virus varied with the age of the animals. In initial studies with the p.10 Jimenez virus, both adult and subadult hamsters were used, but, to obtain blood and fresh tissue samples before death, some of the animals were killed when they appeared to be severely ill. Later, it was observed that not all of the sick animals died and that some recovered spontaneously. For these reasons, we were unable to determine accurately the mortality rate. However, on the basis of limited data from the experiments shown in table 1 and from other subsequent unpublished studies, we estimated that the mortality rate after ip inoculation of 10 6 TCID 50 of the Jimenez p.10 virus in subadult (4-6 weeks old) female hamsters was ∼80%, whereas in older (16 weeks old) female hamsters, the mortality rate was only 15%-20%. The level of viremia and immune response in the 2 age groups did not appear to be significantly different, but the degree of liver pathology in the younger age group was more severe [17] .
Discussion
The viremia, immune response, and abnormalities in liverfunction tests observed in hamsters after infection with YF virus are quite similar to those in rhesus monkeys (Macaca mulatta), as described elsewhere [11, 12, 14, 15] , the current preferred animal model for studies of the disease. As reported in the accompanying paper [17] , the pathology of YF in the hamster and rhesus monkey are also very similar. The major difference between YF virus infection in macaques and hamsters is that rhesus monkeys, regardless of age, develop a rapidly progressive disease that is usually fatal [11, 13, 14, 23] , whereas many adult hamsters survive the infection. In this regard, the disease in adult hamsters is more similar to YF virus infection in humans, in whom the estimated fatality rate is ∼23% [24] . On the basis of these preliminary data, we believe that the hamster-YF model actually may be a better animal model than macaques for studying the pathogenesis, pathophysiology, and treatment of human YF. Hamsters also are considerably cheaper and easier to work with than are monkeys.
There is a paucity of information on the pathophysiology of YF in the human host. The course of viremia and the immune response during the acute phase of natural YF virus infection in humans has never been documented [1, 2] . Furthermore, most of the pathologic descriptions of YF in humans are based on studies of autopsies on patients who died; thus, they only represent changes observed during the terminal stage of the disease [9, [24] [25] [26] . Part of the reason for this lack of information is that YF, at present, is largely a tropical forest-associated disease; human cases generally occur in remote areas with limited laboratory and diagnostic capabilities. Also, YF is a disease of sudden onset and rapid progression, so most patients do not come for medical care until they are in the third stage (period of intoxication) of the illness [1, 2, 24, [27] [28] [29] [30] . At this late stage of the illness, viremia is usually absent, HI antibodies are present, and liver-function studies are grossly abnormal. This period would be equivalent to day 5 or 6 in the hamster model.
Hemorrhagic diatheses are a major component of YF in humans; in fact, coffee-ground hematemesis ("black vomit") is one of the hallmarks of the disease [1, 24, 28] . Hemorrhagic manifestations are less common in the YF-rhesus monkey model, although marked coagulation abnormalities occur in macaques experimentally infected with YF virus [11, [13] [14] [15] . We did not examine this aspect of the disease in our preliminary studies of the YF-hamster model; however, it was observed that blood obtained by cardiac puncture from the experimentally infected hamsters on days 5 and 6 of illness often did not clot in tubes. Thus, it seems likely that hamsters also have coagulation abnormalities during the acute phase of YF virus infection. This aspect of the disease will be examined in future studies.
The relatively high levels of YF viremia found in the experimentally infected hamsters on days 2-4 (table 1) suggest that viremic hamsters also could be used as vertebrate hosts to infect mosquitoes for studies of YF vector competence. Using viremic monkeys, Kumm and Laemmert [31] demonstrated that YF blood-virus levels of 10 5 infected ∼50% of Aedes aegypti, the urban mosquito vector. At levels of viremia у10 6 , almost all the feeding mosquitoes were infected. Levels of viremia observed in the infected hamsters on day 3 often exceeded this titer (table 1). Many of the early studies on the epidemiology and mosquito transmission of YF were done by using monkeys [31] [32] [33] [34] [35] . However, as noted before, use of nonhuman primates for such studies are now practically prohibitive because of the cost and regulatory issues involved. Thus, the hamster also would appear to be a promising alternative for this type of research.
